Zacks Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-733
| Closed | -$40K | – | 600 |
|
|
2017
Q1 | $40K | Buy |
+733
| New | +$40K | ﹤0.01% | 632 |
|
|
2016
Q4 | – | Sell |
-755
| Closed | -$46K | – | 651 |
|
|
2016
Q3 | $46K | Sell |
755
-3,824
| -84% | -$233K | ﹤0.01% | 639 |
|
|
2016
Q2 | $302K | Buy |
4,579
+101
| +2% | +$6.66K | 0.01% | 500 |
|
|
2016
Q1 | $254K | Buy |
4,478
+1,807
| +68% | +$102K | 0.01% | 523 |
|
|
2015
Q4 | $628K | Buy |
+2,671
| New | +$628K | 0.02% | 384 |
|